David Wright of Vanderbilt University in the U.S. will develop a diagnostic that combines sample concentration and multiplex detection into one rapid test that can detect the low levels of the malaria parasite in asymptomatic patients. They will develop a vertical flow component to accommodate larger sample volumes, which will increase the sensitivity of the adjacent lateral flow assay. They will mark the position of a fold on the diagnostic for delivering the isolated biomarkers on one side to the lateral flow assay on the other, which will then present the results using colored lines. They will test their diagnostic against the best commercially available test.
More information about Explore New Solutions in Global Health Priority Areas (Round 17)